Milton Lifecare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Milton Lifecare Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $318.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Milton Lifecare Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $318.7K Trade | TransData Nexus

Milton Lifecare Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $318.7K Total Trade · DGFT Verified

Milton Lifecare Private Limited is an Indian pharmaceutical exporter with a total trade value of $318.7K across 2 products in 2 therapeutic categories. Based on 23 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Budesonide ($299.6K), Nicotine ($19.2K), .

Milton Lifecare Private Limited — Export Portfolio & Destination Treemap

Milton Lifecare Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Milton Lifecare Private Limited? — Company Overview & Market Position

Milton Lifecare Private Limited, established on March 7, 2006, is a private limited company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24230MH2006PTC160312. Its authorized capital is ₹500,000, with a paid-up capital of ₹200,000. The registered office is located at 19 & 20, Floor-1st Floor, Plot-18/19,2, Maker Bhavan, Vitthaldas Thackarsey Marg, New Marine Lines, Churchgate, Mumbai 400020, Maharashtra, India.

The company's primary business activity is the wholesale trade of pharmaceutical and medical goods. Milton Lifecare Private Limited is classified as a medium enterprise under the MSME classification for the financial year 2024-25.

What Does Milton Lifecare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Budesonide$299.6K 2Nicotine$19.2K

Product Portfolio — Top 2 by Export Value

Milton Lifecare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Budesonide	Respiratory	$299.6K	19	0.2%	15
2	Nicotine	Other	$19.2K	4	0.1%	10

Milton Lifecare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $318.7K. The top category is Respiratory (94.0% of portfolio), followed by Other (6.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Milton Lifecare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding Milton Lifecare Private Limited's manufacturing facilities, including their locations, capacities, and specializations, are not publicly available. The company's operations primarily focus on the wholesale distribution of pharmaceutical and medical goods, as indicated by its business activities.

3Key Leadership

The key executives of Milton Lifecare Private Limited include:

Anil Chhaganlal Jain: Director since March 7, 2006.
Akshay Anil Jain: Director since April 4, 2009.
Hitesh Bhupendra Shah: Director since April 4, 2009.
Harshil Hitesh Shah: Additional Director since June 14, 2024.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Milton Lifecare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Milton Lifecare Private Limited's export activities, as per TransData Nexus proprietary trade data, include:

Total Export Value: $319,000 USD.
Total Shipments: 23.
Products Exported: 2 across 2 therapeutic categories.
Top 5 Products:
Budesonide: $300,000, Rank #15, 0.2% market share.
Nicotine: $19,000, Rank #10, 0.1% market share.
Top 3 Categories:
Respiratory: 94.0%.
Other: 6.0%.

Milton Lifecare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Milton Lifecare Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product.

2WHO & EU GMP

Specific details regarding Milton Lifecare Private Limited's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly available. The company's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product.

3CDSCO & Indian Regulatory

Specific information regarding Milton Lifecare Private Limited's manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), approvals from state drug controllers, and export No Objection Certificates (NOCs) is not publicly available. The company's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product.

Milton Lifecare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Milton Lifecare Private Limited's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product. The company's portfolio concentration, with the top 5 products accounting for 100% of exports, suggests a specialized approach. However, specific information regarding the company's competitors in overlapping categories, market share comparisons, and head-to-head analyses is not publicly available.

2Key Differentiators

Milton Lifecare Private Limited's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product. The company's portfolio concentration, with the top 5 products accounting for 100% of exports, suggests a specialized approach. However, specific details regarding the company's unique strengths, competitive advantages, and product portfolio distinctions are not publicly available.

3Strategic Position

Milton Lifecare Private Limited's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product. The company's portfolio concentration, with the top 5 products accounting for 100% of exports, suggests a specialized approach. However, specific information regarding the company's current strategic direction—whether in generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services—and its future outlook is not publicly available.

Buyer Due Diligence Brief — Evaluating Milton Lifecare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Milton Lifecare Private Limited's export data indicates a focus on the respiratory therapeutic category, with Budesonide being the leading product. The company's portfolio concentration, with the top 5 products accounting for 100% of exports, suggests a specialized approach. However, specific information regarding the company's overall track record, export volume and consistency, and reliability indicators is not publicly available.

2Certifications to Verify

Importers considering Milton Lifecare Private Limited as a supplier should verify the following certifications:

FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration (FDA) to ensure compliance with U.S. regulations.
WHO-GMP Certification: Verify the company's adherence to World Health Organization's Good Manufacturing Practice standards.
EU GMP Certification: Ensure the company holds valid European Union Good Manufacturing Practice certificates.

Frequently Asked Questions — Milton Lifecare Private Limited

How many pharmaceutical products does Milton Lifecare Private Limited export from India?

Milton Lifecare Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Budesonide ($299.6K), Nicotine ($19.2K). Total export value is $318.7K.

What is Milton Lifecare Private Limited's total pharmaceutical export value?

Milton Lifecare Private Limited's total pharmaceutical export value is $318.7K, based on 23 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Milton Lifecare Private Limited cover?

Milton Lifecare Private Limited exports across 2 therapeutic categories. The largest are Respiratory (94.0%, 1 products), Other (6.0%, 1 products).

Get Full Milton Lifecare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.